Drug hunters face enormous challenges in their efforts to bring new treatments to patients. The traditional process of designing molecules that have the right properties to become safe and effective drug candidates takes approximately five years, requires thousands of molecules to be synthesized in the laboratory for preclinical testing, and costs many millions of dollars.
Antibodies are specialized protein molecules naturally made by our immune system to help fight off infections. Like a well-aimed slingshot, an antibody is capable of hitting and neutralizing the intended target with astonishing precision. Vaccine-induced antibodies and laboratory-produced monoclonal antibodies (mAbs) have transformed healthcare for millions of individuals suffering from serious and life-threatening diseases, including
When I completed my Ph.D. and postdoc in protein modeling, I joined the modeling and informatics group at a large pharmaceutical company. A few years later when I moved to Boston with my family, I had no idea that I’d be making such an important career choice by accepting an Application Scientist (AppSci) position at
Overlooking “the crossroads of the world,” Times Square, Schrödinger’s new New York City office –– occupying four floors of 1540 Broadway –– is a reprieve from the hustle and provides a haven of wellness and sustainability. The new workplace brought together a collaboration of stakeholders from Schrödinger’s leadership team and architecture firm HLW, including HLW’s
